Additionally, MLP is a potential downstream target of PKCα where HCM-associated mutations in MLP exhibit reduced phosphorylation and DCM-association mutations have increased phosphorylation by PKCα [65]. Here, PRKCA is linked to familial dilated cardiomyopathy.